本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

OnKure Therapeutics, Inc.

3.32
+0.340011.41%
盤後3.320.0001+0.00%19:59 EDT
成交量:63.46萬
成交額:199.72萬
市值:4,491.95萬
市盈率:-0.55
高:3.44
開:2.97
低:2.92
收:2.98
52周最高:17.93
52周最低:1.70
股本:1,353.00萬
流通股本:580.82萬
量比:6.32
換手率:10.93%
股息:- -
股息率:- -
每股收益(TTM):-6.0174
每股收益(LYR):-15.2805
淨資產收益率:-142.90%
總資產收益率:-70.95%
市淨率:0.57
市盈率(LYR):-0.22

資料載入中...

2025/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/28

SEC問詢函

Form CORRESP - Correspondence
2024/10/28

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/10/23

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/16

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]